Psychiatric NP Scope of Practice for ADHD in Florida

If you’re a psychiatrist or PMHNP considering telehealth for ADHD treatment, you’ve probably asked yourself: Can I legally prescribe Adderall or other stimulants to a patient I’ve never seen in person?

The answer in 2026 is yes — but with important caveats that every provider needs to understand.

The regulatory landscape for prescribing controlled substances via telehealth has been in constant flux since COVID-19. While federal waivers currently allow ADHD medication prescribing through video visits, those flexibilities expire at the end of 2026, and permanent rules are coming that will change how you practice. Add state-specific variations — from Texas banning NPs from prescribing stimulants entirely to Florida explicitly allowing it for psychiatric care — and the confusion is real.

This guide cuts through the noise. We’ll walk you through the current federal rules, what’s changing in 2027, and the specific requirements in California, Texas, Florida, New York, Pennsylvania, and Illinois. Whether you’re launching a telehealth practice or expanding to new states, here’s what you need to know to stay compliant and keep serving patients.

Federal Rules: Where We Are Now (Through December 2026)

The Ryan Haight Act Waiver: Still Active

Under normal circumstances, the Ryan Haight Online Pharmacy Consumer Protection Act requires an in-person medical evaluation before prescribing any controlled substance via telemedicine. For ADHD providers, this would mean seeing every new patient face-to-face before writing that first Adderall prescription.

But we’re not operating under ‘normal circumstances.’

The DEA and HHS extended the COVID-era telehealth flexibilities for a fourth time in January 2026, pushing the deadline to December 31, 2026. This means:

• You can prescribe Schedule II–V controlled substances (including Adderall, Vyvanse, Ritalin) via telehealth to new patients without an initial in-person exam
• The patient encounter must use real-time, two-way audiovisual communication (video required, not just phone)
• Standard prescribing rules still apply: legitimate medical purpose, proper evaluation, state PDMP checks, and electronic prescribing

This extension gives providers breathing room, but it’s temporary. The DEA has made clear these flexibilities won’t be renewed indefinitely — permanent rules are coming.

What’s Coming: DEA’s Permanent Telemedicine Rules

In January 2025, the DEA previewed three new rules that will govern telehealth prescribing after the temporary waivers end. Here’s what matters for ADHD providers:

1. Telemedicine Special Registration

The DEA is creating a new pathway for providers to prescribe controlled substances via telehealth without in-person exams. To qualify, you’ll need:

• A special DEA registration (separate from your standard DEA number)
• Mandatory checks of a national PDMP database before prescribing
• Strict patient identity verification during video consultations
• Compliance with new safeguards designed to prevent ‘pill mill’ behavior

Telehealth platforms themselves will also need to register with the DEA — the agency is adding corporate-level oversight to prevent the issues that plagued some startups in 2022-2023.

2. The ‘Established Patient’ Exception

If you’ve seen a patient in person at least once (or they’ve been seen by another provider in your shared practice), the new telemedicine restrictions won’t apply. You can continue treating via telehealth indefinitely.

This is huge for hybrid practices. See your ADHD patients in-clinic for the initial evaluation, then transition to convenient telehealth follow-ups without regulatory headaches.

3. Modified 30-Day Supply Rules

The DEA initially proposed limiting telehealth stimulant prescriptions to 30 days, requiring an in-person visit for refills. After receiving over 38,000 public comments — mostly negative — they went back to the drawing board.

The current thinking: Allow initial 30-day prescriptions via telehealth to new patients without special registration, but require either the special registration or an in-person visit for ongoing treatment. This balances access with safety, though final details are still pending.

The Bottom Line for Your Practice

Through 2026: Business as usual. Prescribe ADHD meds via video visits following standard controlled-substance protocols.

Starting 2027: Plan to obtain the telemedicine special registration if you want to continue serving new patients remotely without in-person exams. The application process isn’t live yet, but it’s coming — likely in late 2026.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Rules: Where Location Really Matters

Federal law sets the floor, but states can add their own requirements. Here’s what you need to know in our priority states:

California: Telehealth-Friendly, NP Independence Coming

The Short Version: No state barriers to telehealth ADHD prescribing. NPs transitioning to full independence by 2026.

Key Rules:

• No in-person exam required by California law for prescribing via telehealth — the state explicitly recognizes telehealth evaluations as valid for controlled substance prescriptions
• PDMP mandatory: Check the CURES database before the initial prescription and every 4 months for ongoing Schedule II therapy
• E-prescribing required for all controlled substances

NP Scope of Practice:

California passed AB 890 in 2020, creating a pathway to independent practice for nurse practitioners. As of 2026:

• New NPs need a supervising physician initially (standard collaborative practice)
• Experienced NPs (3 years/4,600 hours under supervision) can apply for independent NP certification and prescribe stimulants without physician oversight
• By the end of 2026, all qualified NPs can practice and prescribe independently

This expands the pool of ADHD providers significantly in a state with massive demand.

Licensing:

• Must hold a California medical or nursing license (no telehealth registration option)
• California is NOT in the Interstate Medical Licensure Compact — expect a standard licensing process

Practical Tip: California’s regulations are clear and permissive. Your biggest compliance task is PDMP documentation. Make checking CURES part of your standard workflow for every new ADHD patient and set calendar reminders for the 4-month follow-up checks.

Texas: Physicians Only for Stimulants

The Short Version: Telehealth allowed, but NPs and PAs cannot prescribe Schedule II stimulants in outpatient settings. Period.

Key Rules:

• Physicians (MD/DO) can prescribe ADHD medications via telehealth with no state restrictions beyond federal law
• NPs and PAs are prohibited from prescribing Schedule II controlled substances to outpatients — the only exceptions are hospital inpatient orders (≥24 hours), hospice care, or ER emergency orders
• PDMP: Texas law mandates checks for opioids, benzos, barbiturates, and carisoprodol — technically not required for stimulants, but strongly recommended as best practice

Why This Matters:

Texas is one of the most restrictive states for nurse practitioner prescribing authority. If you’re a PMHNP wanting to treat ADHD patients in Texas via telehealth, you’ll need a physician collaborator to actually sign the prescriptions. The NP can evaluate, diagnose, and manage the patient — but a Texas-licensed psychiatrist must write the Adderall script.

For platforms like Klarity operating in Texas, this means either:

1. Only using MD/DO providers for ADHD medication management
2. Pairing NPs with supervising psychiatrists who handle the controlled substance prescriptions

Licensing:

• Texas requires a state medical license for physicians (available via IMLC for expedited processing)
• All controlled substance prescribers must use electronic prescribing (mandated since 2021)

Practical Tip: If you’re a psychiatrist, Texas is straightforward — just follow the federal rules and document your video evaluations properly. If you’re an NP, factor the physician collaboration requirement into your practice model and compensation structure.

Florida: Explicit Psychiatric Exception

The Short Version: Florida law specifically allows Schedule II prescribing via telehealth for psychiatric disorders — ADHD explicitly qualifies.

Key Rules:

• Psychiatric exception: Florida Statutes §456.47 permits telehealth providers to prescribe Schedule II controlled substances for treatment of psychiatric disorders, inpatient care, hospice, or nursing facilities
• ADHD falls under ‘psychiatric disorder’ — you can prescribe stimulants via video visit without an in-person exam
• Out-of-state providers can register with Florida’s Department of Health to treat FL patients via telehealth (no full FL license required, but the registration has requirements)

NP Scope of Practice:

Florida has complex but workable rules for psychiatric NPs:

• Psychiatric nurses (PMHNPs with advanced degree + 2 years post-grad psych experience) can prescribe Schedule II medications for mental health without the 7-day supply limit that applies to other APRNs
• Must practice under a protocol agreement with a supervising psychiatrist (Florida does NOT grant full independence to psych NPs)
• For patients under 18, additional pediatrician or psychiatrist consultation required

PDMP:

• Mandatory check of Florida’s E-FORCSE database before prescribing controlled substances to patients age 16+
• Very few exceptions (3-day non-refillable supplies, certain inpatient settings)

Licensing Options:

1. Full Florida license (standard route)
2. Out-of-state telehealth registration — available to providers licensed in another state with clean record, malpractice insurance, and meeting other criteria

The out-of-state registration is a significant advantage for building a nationwide telehealth practice. A New York psychiatrist could register in Florida and legally prescribe ADHD medications to Florida patients via video visits.

Practical Tip: Florida’s clear statutory language makes compliance straightforward. Document that your care falls under ‘treatment of a psychiatric disorder’ in your clinical notes. If you’re an NP, ensure your supervising psychiatrist agreement explicitly covers telehealth ADHD care and controlled substance protocols.

New York: Recently Updated, PDMP-Heavy

The Short Version: New York aligned its regulations with federal telehealth rules in May 2025. Prescribing allowed, but PDMP checks are strictly enforced.

Key Rules:

• May 2025 update: NY Department of Health explicitly allows controlled substance prescribing via telehealth when consistent with federal law (removing previous state-level barriers)
• PDMP mandatory for every Schedule II prescription — must check the I-STOP/PMP registry before prescribing any stimulant (highly enforced)
• E-prescribing required for all controlled substances since 2016 (NY was an early adopter)

NP Scope of Practice:

New York is relatively progressive:

• Experienced NPs (>3,600 practice hours) can practice independently without a written collaborative agreement
• All NPs can prescribe Schedule II–V controlled substances with their DEA registration
• No quantity limits on NP prescribing of stimulants (same authority as physicians)

Unique NY Advantage: New York allows up to 90-day stimulant prescriptions for ADHD if the prescription indicates it’s for ‘minimal brain dysfunction’ or ADHD (code ‘B’ on the prescription). This reduces the monthly refill hassle for stable patients.

Licensing:

• Must hold a New York medical or nursing license
• Not in IMLC for physicians; no telehealth registration option

Practical Tip: Make PDMP checks non-negotiable in your workflow — New York’s I-STOP program is one of the most strictly monitored in the country. The 90-day prescription option is a quality-of-life improvement for both you and your patients once treatment is established and stable.

Pennsylvania: Collaborative Practice Required for NPs

The Short Version: Telehealth allowed with standard of care. NPs limited to 30-day Schedule II supplies.

Key Rules:

• No state telehealth prescribing restrictions beyond federal requirements
• Standard of care emphasis: PA medical boards stress that telehealth evaluations must be thorough (not just questionnaires)
• PDMP: Required check before initial controlled substance prescription and periodically thereafter
• E-prescribing mandatory since October 2019

NP Scope of Practice:

Pennsylvania requires collaborative practice:

• CRNPs must have a collaborative agreement with a physician to practice and prescribe
• 30-day maximum on Schedule II prescriptions by NPs
• Any continuation beyond 30 days requires physician approval (not necessarily seeing the patient, but consulting with the collaborating doctor)
• Physician must be available for consultation on the NP’s controlled substance prescribing

Licensing:

• PA license required (physicians can use IMLC for expedited processing — PA joined in 2022)

Practical Tip: If you’re an NP in Pennsylvania, build a strong working relationship with your collaborating psychiatrist. The 30-day review requirement means you’ll need their input monthly for ADHD patients on stimulants — make this process efficient with clear protocols and regular case reviews.

Illinois: Two-Tier NP System

The Short Version: Telehealth friendly. NPs can achieve full independence, but those without it face 30-day limits and monthly physician reviews.

Key Rules:

• No state telehealth barriers to prescribing controlled substances
• Illinois controlled substance license required in addition to DEA registration
• Telehealth parity law in effect (strong support for tele-mental health)

NP Scope of Practice — This Gets Interesting:

Illinois has a two-tier system for APRNs:

Tier 1: Under Collaboration

• NP must have written collaborative agreement with physician
• 30-day maximum on Schedule II prescriptions
• Continuation beyond 30 days requires physician approval
• Physician must monthly review the NP’s Schedule II prescribing (chart review requirement)

Tier 2: Full Practice Authority (FPA)

• Available after 4,000 hours of practice under collaboration + 250 hours of continuing education
• Can prescribe Schedule II–V independently without physician collaboration
• Important exception: For Schedule II narcotic drugs (opioids) and benzodiazepines, even FPA NPs need a consultation relationship with a physician
• ADHD stimulants are NOT narcotics — they’re non-narcotic Schedule II substances, so FPA NPs can prescribe them independently without physician consults

This means an experienced PMHNP with FPA certification in Illinois can run an independent ADHD telehealth practice prescribing stimulants without any physician involvement.

PDMP:

• Not explicitly mandated for stimulants by law (required for opioids and first-time benzos)
• Recommended as best practice

Licensing:

• Illinois license required for all providers
• Physicians can use IMLC

Practical Tip: If you’re an NP in Illinois, pursuing FPA certification unlocks significant practice independence for ADHD care specifically (since stimulants fall outside the narcotic consultation requirement). For newer NPs under collaboration, factor in the monthly physician review requirement when structuring your practice.

Compliance Essentials: What Every Provider Must Do

Regardless of your state, these practices are non-negotiable:

1. Use Video for Initial Evaluations

Audio-only is not sufficient for prescribing controlled substances under federal guidance. Your platform must support HIPAA-compliant, real-time audiovisual communication.

2. Check the PDMP

Most states now mandate PDMP checks before prescribing controlled substances. Even if your state doesn’t explicitly require it for stimulants, checking for overlapping prescriptions is standard of care and protects you from liability.

Document every PDMP query in the patient’s chart.

3. Document Like You Would In-Person

Your clinical notes must support the diagnosis and treatment plan. Include:

• Detailed psychiatric history
• DSM-5 criteria met for ADHD
• Rationale for medication selection and dosing
• PDMP review findings
• Discussion of risks, benefits, and alternatives

Telehealth doesn’t lower the documentation standard — if anything, be more thorough given the heightened scrutiny around stimulant prescribing.

4. Use Electronic Prescribing

Nearly every state now requires e-prescribing for controlled substances (EPCS). Ensure your telehealth platform integrates with an EPCS-certified system.

5. Stay Current on State Board Requirements

Medical boards are updating telehealth guidance regularly. Subscribe to your state medical board or nursing board newsletters and check for updates quarterly.

The Economics: Why Telehealth ADHD Care Makes Sense

Let’s talk about the business case.

Traditional patient acquisition for a psychiatric practice is expensive and uncertain. Here’s the reality most providers face:

DIY Marketing Costs:

• SEO investment: 6-12 months of consistent content, technical optimization, and link-building before you see meaningful patient flow. Budget $2,000-5,000/month if you hire an agency, or invest hundreds of unpaid hours if you DIY
• Google Ads: Mental health keywords run $15-40+ per click. Most clicks don’t convert. Realistic cost per booked patient: $200-400+ after accounting for wasted clicks, landing page optimization, and no-shows from cold leads
• Psychology Today/Zocdoc: Monthly subscription fees ($30-150/month) plus pay-per-booking charges ($35-100+ per appointment on Zocdoc). You’re competing with hundreds of other providers on the same search results
• Hidden costs: Staff time qualifying leads, managing multiple marketing channels, testing campaigns that fail, and the opportunity cost of time not spent seeing patients

Total realistic cost to acquire a qualified psychiatric patient through DIY marketing: $200-500+ when you account for all expenses and failed efforts. And you pay those costs upfront, with no guarantee of ROI.

The Platform Model Alternative:

Platforms like Klarity Health use a pay-per-appointment model — you pay a standard listing fee only when a qualified patient books with you. No upfront marketing spend, no monthly subscription gambling, no wasted ad budget.

The value proposition is simple:

• Pre-qualified patients already matched to your specialty (ADHD, in this case) and availability
• No marketing risk — you only pay when you actually see a patient
• Built-in telehealth infrastructure — no separate platform costs or technical setup
• Both insurance and cash-pay patient flow depending on your preference
• You control your schedule — scale up or down as desired

Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a patient appointment happens. That’s guaranteed ROI versus gambling on marketing channels that might not work.

Can you eventually build cost-effective patient acquisition yourself? Sure — if you have the budget to sustain 6-12 months of SEO investment, the expertise to execute effectively, and the patience to test and optimize campaigns while competitors outbid you. Most providers, especially those starting out or scaling, don’t have that luxury.

A telehealth platform that handles patient acquisition removes the risk entirely. You focus on what you do best — clinical care — while the platform handles what it does best: connecting patients with providers.

FAQ: Your Top Questions Answered

Can I prescribe ADHD medications to a patient I’ve never met in person?

Yes, through December 31, 2026, under federal telehealth flexibilities. After that, you’ll likely need a DEA telemedicine special registration or must have seen the patient in person at least once. State rules vary — check your specific state requirements above.

Do I need a separate DEA registration for telehealth prescribing?

Not currently. Your standard DEA registration covers telehealth prescribing under the existing waiver. Starting in 2027 (tentatively), you’ll need to obtain a ‘Telemedicine Special Registration’ from the DEA if you want to continue prescribing to new patients remotely without in-person exams.

Can psychiatric nurse practitioners prescribe Adderall via telehealth?

Depends entirely on your state:

• Yes, independently: California (if FPA-certified), Illinois (if FPA-certified), New York (if experienced)
• Yes, with physician collaboration: Florida (protocol required), Pennsylvania (30-day limit), Illinois (without FPA)
• No: Texas (physicians only for Schedule II outpatient prescriptions)

What happens if I prescribe across state lines?

You must be licensed in the state where the patient is located at the time of the telehealth visit. You also need a DEA registration that covers that state. Treating a Florida patient while licensed only in New York is illegal, even via telehealth.

How often do I need to check the state PDMP?

Varies by state:

• Every prescription: New York (for all Schedule II)
• Initial prescription + every 4 months: California
• Initial prescription + periodic reviews: Pennsylvania, most other states
• Best practice: Check before every controlled substance prescription, even if not strictly required

Can I do audio-only visits for ADHD medication management?

No. Federal guidance requires real-time, two-way audiovisual communication for prescribing controlled substances via telehealth. Phone-only visits don’t meet the standard.

What if my state doesn’t have clear telehealth prescribing laws?

Follow federal rules (currently the DEA extension through 2026) and your state medical/nursing board’s general prescribing standards. Document that your telehealth encounter meets the same standard of care as in-person. When in doubt, consult your state medical board or a healthcare attorney.

Do I need malpractice insurance that covers telehealth?

Yes. Verify your malpractice policy explicitly covers telemedicine/telehealth practice. Many older policies didn’t include this coverage. If you’re practicing in multiple states, ensure your policy covers you in each state where you hold a license.

Next Steps: Getting Started with Telehealth ADHD Care

The regulatory landscape is complex, but the opportunity is real. ADHD is massively underserved — diagnosis rates are climbing, wait times for psychiatrists are measured in months, and patients increasingly prefer the convenience of telehealth.

If you’re ready to start or expand your telehealth ADHD practice:

1. Verify Your LicensesMake sure you’re licensed in every state where you want to treat patients. For psychiatrists, consider IMLC states for faster additional licenses. For NPs, check if your state has reciprocity agreements or if you need to apply separately.

2. Obtain Your DEA Registration(s)You need a DEA registration that covers each state where you’ll prescribe. Apply through the DEA website — processing typically takes 4-6 weeks.

3. Set Up EPCSIf you don’t already have electronic prescribing capability for controlled substances, implement it now. Most EHR and telehealth platforms offer EPCS integration.

4. Register with State PDMPsCreate accounts in each state’s prescription monitoring program database where you’ll be prescribing. Integrate PDMP checks into your clinical workflow.

5. Choose Your Practice ModelDecide whether you’re building your own telehealth practice (higher cost, higher control) or joining a platform that handles patient acquisition and infrastructure (lower risk, faster ramp-up).

6. Stay InformedSubscribe to DEA and state medical board updates. The telehealth prescribing landscape will change significantly in 2027 when permanent federal rules take effect.

Join Klarity Health’s Provider Network

If you’re a psychiatrist or psychiatric nurse practitioner looking to expand your practice with telehealth ADHD care, Klarity Health offers a straightforward path.

Our platform handles:

• Patient acquisition and matching (you only pay when you see patients)
• Telehealth infrastructure (HIPAA-compliant video, EPCS integration, documentation tools)
• Credentialing and compliance support across multiple states
• Both insurance and cash-pay patient flow

You control your schedule, set your rates, and focus on clinical care. We handle everything else.

Ready to learn more? Visit Klarity Health’s provider portal to explore joining our network.

This guide reflects federal and state regulations as of February 2026. Telehealth prescribing rules are evolving — always verify current requirements with the DEA and your state medical/nursing board before beginning practice.

Sources and References

The regulatory details in this guide are drawn from official government sources and verified professional resources:

1. DEA & HHS Press Release – Extension of Telemedicine Flexibilities Through 2026. U.S. Department of Health and Human Services, January 2, 2026. Available at: https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. DEA Press Release – Three New Telemedicine Rules to Continue Open Access. U.S. Drug Enforcement Administration, January 16, 2025. Available at: https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. New York State Department of Health – Bureau of Narcotic Enforcement Guidance on Prescribing Controlled Substances via Telehealth. New York State Department of Health, May 21, 2025. Available at: https://www.ninthdistrict.org/home/2025/05/30/nysdoh-issues-guidance-on-prescribing-controlled-substances-via-telehealth

4. Florida Statutes §456.47 – Telehealth and Controlled Substance Prescribing. Florida Legislature, effective July 2019 (current through 2026). Available at: https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

5. Texas Board of Nursing – APRN Practice FAQ on Prescriptive Authority. Texas Board of Nursing, current as of 2025. Available at: https://www.bon.texas.gov/faqpracticeaprn.asp.html

All state-specific regulations and scope of practice rules were verified against current statutory and administrative code sources as of February 2026.

Source:

• https://www.healthcaredive.com/news/dea-hhs-extend-telehealth-controlled-substance-prescriptions-flexibilities-fourth-time/808735/#:~:text=,II%20to%20Schedule%20V%20drugs
• https://www.healthcaredive.com/news/dea-hhs-extend-telehealth-controlled-substance-prescriptions-flexibilities-fourth-time/808735/#:~:text=,to%20hash%20out%20permanent%20regulations
• https://rxagent.co/blog/np-prescribing-authority#:~:text=Proposed%20DEA%20rules%20create%20a,for%20telemedicine%20prescribing
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=there%20any%20settings%20other%20than,may%20prescribe%20Schedule%20II%20controlled
• https://www.ninthdistrict.org/home/2025/05/30/nysdoh-issues-guidance-on-prescribing-controlled-substances-via-telehealth#:~:text=as%20such%20terms%20are%20defined,the%20use%20of%20electronic%20prescribing
• https://www.pacodeandbulletin.gov/secure/pacode/data/049/chapter21/chap21toc.html#:~:text=,
• https://www.ilga.gov/agencies/JCAR/EntirePart?titlepart=06801300#:~:text=match%20at%20L5536%203,collaborating%20physician%20or%20podiatric%20physician
• https://rxagent.co/blog/np-prescribing-authority#:~:text=However%2C%20,3
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care